TRENTON, N.J., Feb. 28, 2018 /PRNewswire/ -- Therap announces a free webinar for New Jersey
The upcoming webinar presents an opportunity to discuss public partnerships and recent changes to Therap's New Jersey Unusual Incident Report (UIR), part of the system's comprehensive incident report management system. The webinar also will review the billing invoice process for state providers and the flow of claims management within Therap, part of a longer series on billing and claims scheduled in 2018 for New Jersey provider billing & finance departments.
The changes to NJ FamilyCare (NJFC) and residential setting providers operating under the Community Care Program (formerly Community Care Waiver) are discussed, with per-diem reimbursement rates, and how providers would note changes from the daily rate for admission, discharge and hospitalization. Therap's billing support specialists and New Jersey implementation team with experience operating similar Fee-For-Service billing mechanics in other states, will be on-hand during the webinar to demonstrate how those changes will look within the system.
Therap team members will also review the clarification rules for billing units, including how face-to-face time and non-face-to-face time can be delineated and captured for separate billable units, along with rounding rules within the system that can be configured to match guidelines set forth by the Division of Developmental Disabilities and preparations for the Division of Medical Assistance and Health Services (DMAHS). Application of procedural codes for Current Procedural Terminology (CPT) and Health Care Procedure Coding System (HCPCS) within the claims and service authorizations to adjust billing will also be reviewed.
Please register for the webinar
Learn more at www.TherapServices.net.
View original content:http://www.prnewswire.com/news-releases/therap-announces-free-new-jersey-webinar-on-recent-updates-to-fee-for-service-300606185.html
SOURCE Therap Services
Subscribe to our Free Newsletters!
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...View All